APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
49 hedge funds and large institutions have $14.7M invested in Aptose Biosciences, Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $18.8M → $14.7M (-$4.07M)
Holders
49
Holding in Top 10
–
Calls
$38K
Puts
$10K
Top Buyers
| 1 | +$244K | |
| 2 | +$78.6K | |
| 3 | +$45.8K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$44.1K |
| 5 |
VF
Virtu Financial
New York
|
+$25.2K |
Top Sellers
| 1 | -$281K | |
| 2 | -$264K | |
| 3 | -$127K | |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$76.9K |
| 5 |
D.E. Shaw & Co
New York
|
-$58K |